Literature DB >> 5324105

The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis.

P N Skowron, J A Turner, G A McNaughton.   

Abstract

Many practitioners have considered that steroids, with their anti-inflammatory properties, should be efficacious in the treatment of acute laryngotracheitis. To examine this theory, 200 consecutive cases of acute laryngotracheitis admitted to The Hospital for Sick Children, Toronto, were included in a double-blind study using dexamethasone-21-phosphate and placebo according to a random selection code. All other therapy was kept constant. Each patient was assessed by one observer according to seven clinical parameters.The results of this study were subjected to statistical analysis and significantly favoured the steroid-treated group in four parameters only. In view of the risks inherent in steroid therapy, this degree of difference is not sufficient to warrant routine use of this drug for patients with acute laryngotracheitis.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5324105      PMCID: PMC1936541     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  The role of the otolaryngologist in the management of acute laryngotracheitis.

Authors:  B FEARON
Journal:  Can Med Assoc J       Date:  1954-11       Impact factor: 8.262

2.  Present-day aspects of acute laryngotracheitis.

Authors:  J A TURNER
Journal:  Can Med Assoc J       Date:  1954-04       Impact factor: 8.262

3.  Corticotropin (ACTH) in the treatment of acute laryngotracheitis.

Authors:  J A TURNER; E A MORGAN
Journal:  AMA Am J Dis Child       Date:  1952-04
  3 in total
  8 in total

1.  Steroid therapy for croup in children admitted to hospital. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

2.  Corticosteroids in acute laryngotracheitis.

Authors:  G E Breen
Journal:  Can Med Assoc J       Date:  1966-06-11       Impact factor: 8.262

Review 3.  Management of childhood croup.

Authors:  W B Macdonald; G C Geelhoed
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

Review 4.  A risk-benefit assessment of corticosteroids in the management of croup.

Authors:  R W Yates; I J Doull
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

5.  Laryngotracheobronchitis: 2 years' experience with racemic epinephrine.

Authors:  O P Singer; W J Wilson
Journal:  Can Med Assoc J       Date:  1976-07-17       Impact factor: 8.262

Review 6.  Infectious disease emergencies. Part III: Patients presenting with respiratory distress syndromes.

Authors:  P A Oill; S M Roser; J E Galpin; I Ziment; P A Selecky; J Schofferman
Journal:  West J Med       Date:  1976-12

Review 7.  Management of croup.

Authors:  Wendy Stannard; Chris O'Callaghan
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Glucocorticoids for croup in children.

Authors:  Allison Gates; Michelle Gates; Ben Vandermeer; Cydney Johnson; Lisa Hartling; David W Johnson; Terry P Klassen
Journal:  Cochrane Database Syst Rev       Date:  2018-08-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.